Literature DB >> 7964849

The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.

F G van der Meché1.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7964849      PMCID: PMC1016721          DOI: 10.1136/jnnp.57.suppl.33

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

2.  Residual signs in severe Guillain-Barré syndrome: analysis of 57 patients.

Authors:  A E de Jager; J M Minderhoud
Journal:  J Neurol Sci       Date:  1991-08       Impact factor: 3.181

3.  A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

Authors:  J B Winer; R A Hughes; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

4.  Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis.

Authors:  G M McKhann; J W Griffin; D R Cornblath; E D Mellits; R S Fisher; S A Quaskey
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

5.  Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.

Authors: 
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

6.  Plasma exchange morbidity in Guillain-Barré syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group.

Authors:  J Bouget; S Chevret; C Chastang; J C Raphael
Journal:  Crit Care Med       Date:  1993-05       Impact factor: 7.598

7.  [The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases].

Authors:  J C Raphael; C Masson; V Morice; D Brunel; P Gajdos; A Barois; M Goulon
Journal:  Rev Neurol (Paris)       Date:  1986       Impact factor: 2.607

8.  Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.

Authors:  R P Kleyweg; F G van der Meché
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

9.  Prognostic value of electrodiagnosis in Guillain-Barré syndrome.

Authors:  R G Miller; G W Peterson; J R Daube; J W Albers
Journal:  Muscle Nerve       Date:  1988-07       Impact factor: 3.217

  9 in total
  1 in total

1.  Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Authors:  R Korinthenberg; J S Mönting
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.